Sensible MedicineThis Fortnight in Medicine XXXV5461×0:00Current time: 0:00 / Total time: -38:36-38:36Audio playback is not supported on your browser. Please upgrade.This Fortnight in Medicine XXXVDiscontinuing colon cancer screening and using P-TAU 217 blood tests to predict dementialAdam Cifu, MD, John Mandrola, and Andrew J FoyOct 07, 2026546ShareTranscriptColorectal Cancer and Mortality Risk Among Older Adults With vs Without Adenoma on Prior ColonoscopyThe Hubris of Screening for Disease — AgainPrognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive ImpairmentWhy Blood Tests Are a Poor Screening Tool for Alzheimer’sDiscussion about this episodeCommentsRestacksSensible Medicine reply rulesSensible MedicineCommon sense and original thinking in bio-medicine A platform for diverse views and debateCommon sense and original thinking in bio-medicine A platform for diverse views and debateSubscribeListen onSubstack AppRSS FeedAppears in episodeAndrew J FoyWrites Andrew J Foy SubscribeAdam Cifu, MDJohn MandrolaRecent EpisodesThis Fortnight in Medicine XXXVIIINov 18 • Adam Cifu, MD, Vinay Prasad MD MPH, and John MandrolaThis Fortnight in Medicine XXXVIINov 4 • Adam Cifu, MD, John Mandrola, and Andrew J FoyThis Fortnight in Medicine XXXVIOct 21 • Adam Cifu, MD and Andrew J FoyEpisode 10 - Target TrialsOct 20 • Vinay Prasad MD MPHLecture 9 - multiplicityOct 13 • Vinay Prasad MD MPHThis Fortnight in Medicine XXXIVSep 23 • Adam Cifu, MD, Vinay Prasad MD MPH, and John MandrolaLecture 8 - endpointsSep 22 • Vinay Prasad MD MPH